PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 87 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | -50.0% | 87 | -64.2% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 243 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 243 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 243 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -33.3% | 243 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 243 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | -66.7% | 243 | 0.0% | 0.00% | – |
Q1 2019 | $9,000 | +125.0% | 243 | +17.4% | 0.00% | – |
Q4 2018 | $4,000 | -55.6% | 207 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | -25.0% | 207 | 0.0% | 0.00% | – |
Q2 2018 | $12,000 | -99.2% | 207 | -99.0% | 0.00% | -100.0% |
Q1 2018 | $1,476,000 | -24.4% | 21,694 | +9.9% | 0.01% | -14.3% |
Q4 2017 | $1,952,000 | – | 19,744 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
State of Wyoming | 20,732 | $59,000 | 0.04% |
Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |